tang capital management llc company profile  bloomberg feedback tang capital management llc private company company profile sector financials industry institutional financial svcs subindustry institutional brokerage tang capital management llc operates as a security brokerage firm corporate information address  executive drive suite  san diego ca  united states phone  fax  from the web sponsored financial commentaries more from the web home news top headlines most popular exclusive law entrepreneurs leaders economy environment science sports markets magazine pursuits magazine bloomberg visual data bloomberg best and worst for comments or complaints about news coverage click here regions us china europe asia uk  ireland australia  new zealand canada india  pakistan japan africa eastern europe latin america middle east markets commodities currencies bonds stocks energy markets municipal bonds emerging markets funds islamic finance industries energy technology real estate finance health care transportation insurance retail media manufacturing quick market data stocks stock futures world indexes americas europe middle east  africa asiapacific gainers  losers earnings calendar industry leaders currencies americas europe middle east  africa asiapacific foreign exchange cross rates fx fixings currency converter forex trading videos commodities energy prices metals prices agricultural prices rates  bonds us treasuries uk gilts germany bunds japan bonds australia bonds bloomberg bond indexes corporate bonds consumer rates economic calendar watchlist european debt crisis symbol search the market now personal finance top headlines saving  investing real estate retirement planning financial advisers taxes blog ventured  gained real cost of money gallery calculators watchlist portfolio tracker tech top headlines social media mobile  wireless web enterprise tech tv games  movies apple tech deals global tech slideshows videos us politics sustainability top headlines energy corporate sustainability policy natural resources health  population slideshows videos blog the grid luxury top headlines autos billionaires living property travel well spent loot blog pursuits magazine videos tv live tv channel finder personalities apple tv ipad app schedule us asia europe shows surveillance market makers lunch money street smart bloomberg west game changers video must see latest live tv shows playlist radio live radio shows schedule personalities podcasts bloomberg brief featured podcasts and new shows bloomberg view masters in business first word surveillance bloomberg advantage in the loop bloomberg law taking stock bloomberg best more podcasts blogs global tech the grid loot the market now political capital tech deals ventured and gained opinion my saved registration sign in bloombergcom businessweekcom company about blog careers diversity  inclusion news mission philanthropy  engagement press room procurement sustainability products financial products bloomberg professional service bloomberg anywhere bloomberg tradebook bloomberg briefs bloomberg indexes bloomberg sef service center customer support enterprise products enterprise solutions trading solutions industry products bloomberg bna bloomberg government bloomberg law bloomberg link bloomberg new energy finance bloomberg sports content licensing bloomberg anywhere mobile apps bloomberg visual data tang capital management llc private company information  bloomberg july    pm et capital markets company overview of tang capital management llc snapshot people company overview tang capital management llc is a principal investment firm specializing in investments in life sciences the firm was founded in  and is based in san diego california  executive drivesuite san diego ca united statesfounded in  phone  key executives for tang capital management llc mr kevin c tang managing director age  compensation as of fiscal year  similar private companies by industry company name region visory llc united states  road partners llc united states t partners llc united states jumpcom inc united states  ontario inc united states recent private companies transactions typedate target private placement august   heron therapeutics inc request profile update   the information and data displayed in this profile are created and managed by sp global market intelligence a division of sp global bloombergcom does not create or control the content for inquiries please contact sp global market intelligence directly by clicking here stock quotes market data is delayed at least  minutes company lookup most searched private companies company name geographic region lawyers committee for civil rights under law united states nyc inc united states the advertising council inc united states bertelsmann ag europe rush university united states sponsored financial commentaries sponsored links browse companies a b c d e f g h i j k l m n o p q r s t u v w x y z              request profile update only a company representative may request an update for the company profile documentation will be required to contact tang capital management llc please visit  company data is provided by sp global market intelligence please use this form to report any data issues information missing  please enter your information in the following fields company name your name your email address your phone number type of data overview executives key developments similar companies transactions update needed all data changes require verification from public sources please include the correct value or values and a source where we can verify cancel submit your requested update has been submitted our data partners will research the update request and update the information on this page if necessary research and followup could take several weeks if you have questions you can contact them at bwwebmasterbusinessweekcom close tang capital management llc  san diego  ca  company information products resources my account talk to a db advisor  business directory ca san diego security brokers and dealers security brokers and dealers tang capital management llc t tang capital management llc claim this business  eastgate mall suite  san diego ca  get directions   business info founded  incorporated ca annual revenue  employee count  industries security brokers and dealers contacts contact business your email address subject message send message company summary business services company located in san diego ca established in  verified status unverified address unverified last verified  phone unverified payment method unverified view full report similar businesses nearby our similar businesses nearby shows similar businesses in their industry and region based on information found in their dun  bradstreet credibility review profile competitive landscape our competitive landscape shows how this business compares to similar businesses in their industry and region based on information found in their dun  bradstreet credibility review profile payments accepted no data hours sunday   monday   tuesday   wednesday   thursday   friday   saturday   t view additional data select from over  networks below to view available data about this business if this data is unavailable or inaccurate and you own or represent this business click here for more information on how you may be able to correct it credibility review google facebookcom yellowbookcom bingcom yellowpagescom merchantcircle tele atlas tomtom twittercom aol mapquest yahoo local applesiri groupon hotfrogcom comcastnet search reachlocal admedia dealsplus shoptopiacom alteryx dogtime media kslcom sirtune americantownscom driverside kudzucom specialsagentcom answerscom egood lawinfocom spotlikescom anywhocom egumball likenesscom spotzot eservicelog mapmyrun technocom apartmentguidecom ezlocalcom eztousecom teleroute aroundmecom metropolistcom therapistscom atlanta newhomes findlawcom time out new york avantar findthebestcom mojopagescom bb yellowpages fivestar software mycitywaycom tripadvisor bckyrdcom giftcardscom mycouponscom beachcaliforniacom golocalcom mymovecom upmesocialcom belo goodinfo newsgazette nokia usdirectorycom carscom nomao centzycom hibu openlistcom chacha search homeplatecom ownlocalcom visikard challamacom homestore patchcom voltari citybot pelopidas vouchd classifiedads hostway placeiq walkscorecom cloudmade hoodoyou planetdiscovercom weddingwirecom powerprofiles where inc contractorscom igolocalcom radiate media wikiocity couponmap indeedcom wimgocom crowdspot innova electronics intellistrand realtorcom datasphere inthemocom replycom yellowbotcom jiwire rocket fuel yellowpagecitycom dmvorg justclicklocalcom dirxion keencom zidstercom photos business credit report receive a onetime comprehensive credit report on this company get full credit report facebook twitter yelp call  to speak with a db advisor today customer resources products education center business articles  insights glossary contact us customer support communication preferences search for db duns our company about us company history business credit history careers press releases news success stories hoovers our network partners affiliates blog access to capital entrepreneurial initiative db international supplieredge site links business directory site map pipeda privacy policy website terms of service product license agreement  dun  bradstreet inc  all rights reserved tang capital management llc top holdings whalewisdom search all search f filers only search sec filer search stocks only search mgmt inv cos only etfs only search active tang capital management llc • san diego ca how do i update this listing tang capital management is based out of san diego their last reported f filing for q  included  in managed f securities and a top  holdings concentration of  tang capital managements largest holding is heron therapeuti with shares held of  tang capital management has met the qualifications for inclusion in our whalescore system whalewisdom has at least  f filings in our database for tang capital management equalwtwhalescore   sp whalescore  manager weightedwhalescore  summary f holdings ind managers dg insider form  whalescore history download f summary to excel download f summary to excel create email alert × email notification log in or signup to see more advanced email alert options such as selecting any type of sec form multiple filers or classes of filers and much more or to simply have an email sent to you whenever we receive a new f filing from tang capital management llc enter your email address below and choose submit your email cancel  top buys name change ljpc la jolla pharmac  hrtx heron therapeuti   top sells name change oplk prn oplink communicatio  life atyr pharma inc   f holdings summary stock port hrtx heron therapeuti  ljpc la jolla pharmac  rxdx ignyta inc  bmrn biomarin pharmaceutical inc  cycc cyclacel pharmaceuticals inc  see all holdings  f activity market value  million prior market value  million new purchases stocks additional purchases stocks sold out of stocks reduced holdings in stocks top  holdings  turnover   turnover alt   time held top quarters time held top quarters time held all quarters  turnover is calculated by taking the  of new holdings initial purchases  the  of positions sold out of not just reduced divided by the total  of holdings for the quarter  alt turnover is calculated by taking either the total mv of new purchases or the mv of securities sold whichever is less divided by the total mv of the fund  f sector allocation over time fund metrics you are limited to the prior  quarters of f filings subscribe to whalewisdom to view all filing data for tang capital management llc portfolio performance top  equalweighted holdings last updated on  performance for q   performance last  quarters  performance metrics stdev yrs subscription required beta yrs subscription required alpha yrs subscription required sortino yrs subscription required stutzer yrs subscription required treynor yrs subscription required sterling yrs subscription required calmar yrs subscription required information ratio yrs subscription required tracking error  yrs subscription required stdev down yrs subscription required winning months  subscription required losing months  subscription required best  months subscription required worst  months subscription required efficiency ratio yrs subscription required sharpe subscription required stdev sectors subscription required skewness yrs subscription required kurtosis yrs subscription required upside potential yrs subscription required backtester use whalewisdoms backtester tool to test how a hypothetical portfolio would have performed with different investment strategies research one or more filers performance and then optimize their portfolios to match your own investment goals start with one of our predefined groups or create your own view the backtesting whitepaper and the getting started page for additional help take a tour save changes to tracked backtest saving generate report at least one fund must be selected before running a backtest  ending sector allocation quarter to view current combined fdg q  f filings q  f filings q  f filings q  f filings q  f filings q  f filings q  f filings q  f filings q  f filings subscription required q  f filings subscription required q  f filings subscription required q  f filings subscription required q  f filings subscription required q  f filings subscription required q  f filings subscription required q  f filings subscription required q  f filings subscription required q  f filings subscription required q  f filings subscription required q  f filings subscription required q  f filings subscription required q  f filings subscription required refresh advanced export download csv download excel xlsx download tsv click to see additional filters security types shares calls puts principal changes in holdings new position added to position reduced position closed out position no change ranking is in the top minimum  of shares stock ticker is etf yesno refresh edit columns shares are split adjusted × report an error your name optional your email optional error to report or any other commentsrequired cancel click here to report any possible errors with this listing f filings available   fhr subscription required   fhr subscription required   fhr subscription required   fhr subscription required   fhr subscription required   fhr subscription required   fhr subscription required   fhr subscription required   fhr subscription required   fhr subscription required   fhr subscription required   fhr subscription required   fhr subscription required   fhr subscription required   fhr subscription required   fhr subscription required   fhr subscription required   fhr subscription required   fhr subscription required   fhr subscription required   fhr subscription required   fhr subscription required × csv export module this will schedule a job to export all requested f holdings data for this filer when completed an email will be sent to the email address you specify containing a link to download the zip file of the csv files you requested output type output all f holdings into a single csv file output all f holdings into separate csv files per quarter columns to include filer name stock name stock ticker quarter date type of security current shares held current market value previous shares held previous market value current  of portfolio previous  of portfolio current rank previous rank change in shares type of change sector f quarters to include         email address to send data to cancel schedule export this lets you look at individual sub managers or subsidiaries within the f filing quarter         manager optionally compare to quarter          manager  number of shares is not splitadjusted schedule d and g events since  subscription required form   nonderivative insider transactions since  loading whalescore history for tang capital management llc you must have a subscription to view whalescore histories elevate your investments try it for free tang capital management llc  relationship science news home advertising board and executive moves energy health care hedge funds m  a private equity technology you have    free profiles   left this month    start your free trial ➤ hey we noticed youre a relsci pro subscriber would you like to view the page there view on relsci pro ➤ email linkedin facebook google tweet reddit permalink tang capital management llc overview in the news executives  employees paths investments holdings  top positions tang capital management llc overview date founded  headquarters  executive drive suite  san diego ca  industries hedge funds investment services  portfolio management company description tang capital management focuses on investments in smallcap us companies in the life sciences health technology and process industries sectors in the news see more see full news coverage and complete stories with relsci professional create your news feed see more executives  employees kevin c tang founder see our list of current and previous employees when you upgrade start my free trial ➤ see more paths to tang capital management llc tang capital management llc you connections via relationship science tang capital management llc sync your contacts to see how you can connect with tang capital management llc start my free trial ➤ see more investments details hidden radpharm inc radpharm is a leading imaging core lab managing the complete imaging segment of clinical trials for the global pharmaceutical biotechnology and medical device industries with greater than  years experience supporting over  clinical trials across  countries and  unique sites radpharms vast expertise spans early stage through phase iv studies and all major therapeutic areas in addition to having a specialty in oncology trials they also possess deep experience with cardiovascular musculoskeletal cns diagnostic contrast imaging agents and medical device studiesradpharm employs boardcertified subspecialty trained radiologists nuclear physicians and medical oncologists uniquely positioning us to focus on the medicine behind the imagetm its experienced medical staff interprets data from all major modalities including but not limited to computed tomography ct magnetic resonance imaging mri xray single photon emission computed tomography spect ultrasound positron emission tomography pet and petctthey provide centralized independent unbiased interpretation of medical images for clinical trials integrated with a proven planning tracking and implementation process specifically designed to exceed your expectations and timelines radpharm speeds delivery of your product to market by supporting your trial program with medical expertise regulatory knowhow and advanced validated technologiesradpharm inc provides oncology and medical imaging review services it also offers radiation therapy qa services oncology clinical reviews and complete medical photography services the company was founded in  by robert ford and is headquartered in princeton nj holdings  top positions restricted data only for relsci professional users start my free trial ➤ see more youve reached your  free profiles limit this month upgrade to relsci pro today to enjoy unlimited article views and much more start my free trial ➤ still not convinced check out our full listing of features here are you a relsci pro subscriber login to relsci pro  ➤ not a pro subscriber log in here to manage your alerts keep me signed in login  ➤ forgot your password i have read the lexisnexis terms  conditions sign me up  ➤   kevin c tang  tang capital management   stock picks and performance  insider monkey companies  see all hedge funds  see all insiders  see all institutional investors  see all click here to see all results for sorry no results has been found matching your query adblocker detected dear valued visitor we have noticed that you are using an ad blocker software although advertisements on the web pages may degrade your experience our business certainly depends on them and we can only keep providing you highquality research based articles as long as we can display ads on our pages to view this article you can disable your ad blocker and refresh this page or simply login we only allow registered users to use ad blockers you can sign up for free by clicking here or you can login if you are already a member home  hedge funds  tang capital management  profile hedge fund  tang capital management get email alerts profile holdings latest d  g filings news interviews and investor letters get email alerts profile holdings latest d  g filing news kevin c tang bio returns net worth manager biography is currently missing fund profile filing period                            fund name tang capital management manager kevin c tang portfolio value  change this qtr  top holdings login to see all holdings  sign up filing period                            last updated on may    pm based on sec f filings last update may    pm no security ticker shares value x activity  port  heron therapeutics inc hrtx      la jolla pharmaceutical co ljpc      ignyta inc     biomarin pharmaceutical inc bmrn     cyclacel pharmaceuticals inc cycc     login to see all holdings  sign up its free news interviews and investor letters see all  biggest and most famous activist hedge funds after all activist hedge funds get most of their earnings from investing in companies and pushing them to provide more shareholder value these funds and their managers can start off with a statement read more february nd   hedge funds news  comments heron therapeutics inc hrtx tang capital partners raises stake to  according to a newlyamended d filing with the us sec kevin c tangs tang capital management owns  million shares of heron therapeutics inc nasdaqhrtx the stake amassing  of the company read more april th   hedge funds news  comments heron therapeutics inc shares take wing on big insider buy down  during ordinary trading hours shares of heron suddenly took wing rising  in the afterhours market after it was revealed that director and hedge fund manager kevin tang had made a series read more june rd   hedge funds insider trading news  comments heron therapeutics inc hrtx la jolla pharmaceutical company ljpc salix pharmaceuticals ltd slxp are tang capital’s largest bets in q kevin tangs tang capital partners is one of the funds that have already revealed their equity portfolios as of the end of last year the healthcarefocused investment firm reported an equity portfolio read more january th   hedge funds news  comments tang capital management is getting out of oncogenex pharmaceuticals inc ogxi and cyclacel pharmaceuticals inc cycc kevin c tangs tang capital management has decreased its position it two pharmaceutical companies the  million hedge fund recently decreased its position in oncogenex pharmaceuticals inc nasdaq read more january th   hedge funds news  comments tang capital management discloses moves into la jolla pharmaceutical company ljpcd vanda pharmaceuticals inc vnda mirati therapeutics inc mrtx  others tang capital management led by kevin c tang revealed in a filing several moves that have impacted its equity portfolio one of the companies involved is la jolla pharmaceutical company otcbbljpcd read more january th   hedge funds news  comments click here to see all news hedge fund resource center how to beat the market by  percentage points why track hedge funds download a free edition why you should dump your hedge funds  things you didnt know about hedge funds billionaire hedge funds warren buffett berkshire hathaway  david einhorn greenlight capital  george soros soros fund management  t boone pickens bp capital  jim simons renaissance technologies  leon cooperman omega advisors  carl icahn icahn capital lp  steve cohen point asset management  john paulson paulson  co  david tepper appaloosa management lp  paul tudor jones tudor investment corp  stanley druckenmiller duquesne capital  julian robertson tiger management  ray dalio bridgewater associates  ken fisher fisher asset management  bill ackman pershing square  edward lampert esl investments  dan loeb third point  ken griffin citadel investment group  israel englander millennium management  michael price mfp investors  home hedge funds markets blog authors about us contact us privacy policy terms of use site map all text and design is copyright  koala guide llc all rights reserved biotechfocused star hedge fund tang capitals q  picks in its  million portfolio  seeking alphasign in  join nowgo»biotechfocused star hedge fund tang capitals q  picks in its  million portfolioapr    am et includes achn alxa anip bmy gsk mnkd ogxi optr slxp sppi uthrby gurufundpicksgurufundpicks consensus picks diy tools top  smallcap newsletter trade alert service autogurufundpickssan diego cabased tang capital management founded in  by kevin c tang is a hedge fund that specializes in the life sciences industry prior to founding his firm mr tang was most recently the managing director and head of life sciences research group at deutsche banc alex brown as of the most recent filing for the march  quarter filed with the sec last week it held  million in f assets between firm inception and through may  the firm had generated a total return of  or  on an annualized basis compared to the  average annual return for the sp  over the same period we analyzed tangs biotech holdings in its q  f to determine its highest conviction bets selecting the largest buys and sells in size where the buysell is also a significant proportion of its prior quarter position in that company based on that analysis the following are its high conviction bullish positions that are also trading undervalued compared to the peers in their group see table amylin pharmaceuticals amln amln develops drugs for the treatment of diabetes obesity and other diseases tang added a new  million position in q other leading institutions with large bullish bets on amln in q the most recent quarter for which most institutional filings are available included mega fund t rowe price associates with  billion in f assets adding  million shares to its  million share prior quarter position and hedge fund kingdon capital management with  billion in f assets adding a new  million share position amln shares have mounted a strong rally recently up about  ytd with the biggest surge occurring at the end of march after news broke that the company rejected a  billion unsolicited bid from bristolmyers squib nysebmy a move that effectively put a  floor under the stock on monday the company announced that it had hired bankers and was actively looking to sell itself with astrazeneca plc nyseazn sanofi nysesny and merck nysemrk mentioned as potential suitors that could pay a premium to get access to its valuable byetta  bydureon diabetes portfolio the street has been abuzz over the news with some speculating that the company could ultimately go for as much as  a share still well above wednesdays closing price of  spectrum pharmaceuticals nasdaqsppi sppi develops innovative therapies with a focus in the areas of hematology and oncology tang added a new  million position in q other leading institutions with large bullish bets on sppi in q the most recent quarter for which most institutional filings are available included mutual fund powerhouse fidelity investments with  billion in f assets adding  million shares to its  million share prior quarter position and new yorkbased biotechfocused hedge fund baker bros advisors with  billion in f assets adding a new  million share position sppi shares have been weak since its announcement on april th that its phase  clinical trials in bladder cancer failed to meet the primary endpoint of statistically significant difference in the rate of tumor recurrence the same day it also announced that it way buying allos therapeutics nasdaqalth for share in cash its shares are now down about  ytd after a blockbuster  during which share prices more than doubled furthermore in its most recent q the company missed analyst earnings estimates c vs c while revenues came inline its shares currently trade at  forward pe and  pb compared to averages of  and  respectively for its peers in the drug manufacturers group however earnings are expected to drop from  in  to c in  and c in  salix pharmaceuticals nasdaqslxp slxp develops branded prescription drugs for the treatment of gi diseases tang added a new  million position in q other leading institutions with large bullish bets on slxp in q the most recent quarter for which most institutional filings are available included pittsburgh pabased mutual fund powerhouse federated investors with  billion in assets under management adding  million shares to its  million share prior quarter position and legendary billionaire investor ken griffins chicagobased hedge fund citadel adding a new  million share position slxp shares have performed well recently almost doubling from the lows last september and they currently trade at  forward pe and  pb compared to averages of  and  for its peers in the drug manufacturers group while earnings are projected to increase slightly from  in  to  in  the following are additional companies that tang is bullish about accumulating shares in them in q  see table oncogenex pharma inc nasdaqogxi a biotech company engaged in the development of new cancer therapies that address treatment resistance in cancer patients in which it added a new  million position alexza pharmaceuticals nasdaqalxa a development stage biotech company focused on the research development and commercialization of a novel proprietary drug delivery system for the acute treatment of central nervous system conditions in which it added a new  million position mannkind corp nasdaqmnkd a developer of treatments for cancer diabetes inflammatory and autoimmune diseases with its lead product candidates the afrezza dry powder insulin formulation and its proprietary light discrete and easytouse afrezza inhaler through which the powder is inhaled deep into the lungs in which it added a new  million position human genome sciences hgsi that develops genebased protein and antibody drugs to treat such diseases as hepatitis c lupus anthrax cancer rheumatoid arthritis and hivaids in which it added a new  million position and biosante pharmaceuticals bpax that develops products for female sexual health and oncology in which it added a new  million position the following are tangs high conviction bearish picks based on its q  selling activity see table optimer pharmaceuticals nasdaqoptr that focuses on discovery development and commercialization of hospital specialty products such as products that treat gastrointestinal infections and related diseases in which it cut out completely in q  its  million prior quarter position united therapeutics corp nasdaquthr a biotech company focused on developing therapies to treat cardiovascular inflammatory and infectious diseases in which it cut out completely in q  its  million prior quarter position and achillion pharmaceutical nasdaqachn a clinicalstage biotech focused on developing new treatments to patients with infectious diseases including hcv and resistant bacterial infections in which it cut  million in q  from its  million prior quarter position table credit historical fundamentals including operating metrics and stock ownership information were derived using sec filings data imetrix® by edgar online® zacks investment research thomson reuters and briefingcom the information and data is believed to be accurate but no guarantees or representations are made disclosure i have no positions in any stocks mentioned and no plans to initiate any positions within the next  hours disclaimer material presented here is for informational purposes only nothing in this article should be taken as a solicitation to purchase or sell securities before buying or selling any stock you should do your own research and reach your own conclusion further these are our opinions and we may be wrong we may have positions in securities mentioned in this article you should take this into consideration before acting on any advice given in this article if this makes you uncomfortable then do not listen to our thoughts and opinions the contents of this article do not take into consideration your individual investment objectives so consult with your own financial adviser before making an investment decision investing includes certain risks including loss of principalabout this articleexpandauthor payment   page view authors of pro articles receive a minimum guaranteed payment of tagged investing ideas fund holdings healthcarewant to share your opinion on this article add a commentdisagree with this article submit your ownto report a factual error in this article click herefollow gurufundpicks and get email alerts access to this page has been denied please verify you are a human please click i am not a robot to continue access to this page has been denied because we believe you are using automation tools to browse the website this may happen as a result of the following javascript is disabled or blocked by an extension ad blockers for example your browser does not support cookies please make sure that javascript and cookies are enabled on your browser and that you are not blocking them from loading reference id bccfebbceddb powered by perimeterx  inc access to this page has been denied please verify you are a human please click i am not a robot to continue access to this page has been denied because we believe you are using automation tools to browse the website this may happen as a result of the following javascript is disabled or blocked by an extension ad blockers for example your browser does not support cookies please make sure that javascript and cookies are enabled on your browser and that you are not blocking them from loading reference id bcfcfeabefa powered by perimeterx  inc access to this page has been denied please verify you are a human please click i am not a robot to continue access to this page has been denied because we believe you are using automation tools to browse the website this may happen as a result of the following javascript is disabled or blocked by an extension ad blockers for example your browser does not support cookies please make sure that javascript and cookies are enabled on your browser and that you are not blocking them from loading reference id bccddfeaafcda powered by perimeterx  inc kevin c tang  founder at tang capital management llc news home advertising board and executive moves energy health care hedge funds m  a private equity technology you have    free profiles   left this month    start your free trial ➤ hey we noticed youre a relsci pro subscriber would you like to view the page there view on relsci pro ➤ email linkedin facebook google tweet reddit permalink kevin c tang founder at tang capital management llc overview in the news relationships paths education career history boards  committees political donations public holdings kevin c tang founder at tang capital management llc overview age  born  notable companies tang capital management llc board seats  number of relationships this person is connected to  people in the news see more business wire may   ap pharma appoints new management team see full news coverage and complete stories with relsci professional create your news feed see more relationships see details barry d quart former director chief executive officer at heron therapeutics inc george f tidmarsh president chief executive officer  secretary at la jolla pharmaceutical co robert h rosen president director  chief commercial officer at heron therapeutics inc craig a johnson president chief executive officer altria group distribution company at altria group inc felix baker cofounder at baker bros advisors lp henry j fuchs chief medical officer  executive vice president at biomarin pharmaceutical inc stephen r davis president  chief executive officer at acadia pharmaceuticals inc jack s remington chairmanimmunology  infectious diseases at palo alto medical foundation john w poyhonen president  chief executive officer at senomyx inc jeffrey marc lipton professional at dupont see  more listings with relsci professional start my free trial ➤ see  more paths to kevin c tang kevin c tang you connections via relationship science kevin c tang sync your contacts to see how you can connect with kevin c tang start my free trial ➤ see more educational background bachelor of science degree  class of   duke university duke university is an academic university that offers undergraduate graduate and professional programs it also has publications and research services the university was founded in  and is headquartered in durham nc career history founder   current tang capital management llc tang capital management focuses on investments in smallcap us companies in the life sciences health technology and process industries sectors director prior   intrabiotics pharmaceuticals inc intrabiotics a developer of antibiotics and antifungals is focused on one drug candidate iseganan hydrochloride oral solution which would be used for the prevention of ventilatorassociated pneumonia and to help cystic fibrosis patients fight respiratory infections head of life sciences research group    deutsche bank securities inc founded in  deutsche bank securities inc is an secregistered brokerdealer headquartered in new york city the firm is the investment banking and brokerage arm of deutsche bank ag nyse db they provide investment products underwriting financial advisory services mergers and acquisition advisory brokerage services and financial advice deutsche bank securities focuses primarily on the consumer energy utilities chemicals financial institutions financial sponsors healthcare hospitality leisure industrials media natural resources real estate technology and telecommunications sectors the firm is a member of finra and the sipc boards  committees corporate boards ▾ chairman of the board   current la jolla pharmaceutical co la jolla pharmaceutical co is a biopharmaceutical company which engages in the discovery development and commercialization of innovative therapies intended to significantly improve outcomes in patients suffering from lifethreatening diseases its products includes ljpc ljpc ljpcsa and ljpcsb ljpc is the proprietary formulation for angiotensin ii the ljpc is the formulation of hepcidin which is an endogenous peptide hormone the ljpcsa and ljpcsb are the next generation gentamicin derivatives which is an antibiotic for kidney toxicity the company was founded in  and is headquartered in san diego ca chairman board of directors   current heron therapeutics inc heron therapeutics inc is a biotechnology company develops pharmaceutical products for patients suffering from cancer or pain the company develops products by using its proprietary biochronomer polymer based drug delivery technology its primary products are sustol htx and htx the company has additional clinical and preclinicalstage programs in the area of pain management all of which utilize its bioerodible injectable and implantable delivery systems heron therapeutics was founded in february  and is headquartered in redwood city ca director current prospect therapeutics inc prospect therapeutics inc develops biopharmaceuticals to treat variety of cancers the firms products include gcs for the treatment of leukemia multiple myeloma and lymphoma gcs a proprietary polysaccharide targets galectin a protein overexpressed in cancer cells that promotes their survival proliferation and metastasis the company was founded by joseph grimm george tidmarsh and kevin tang in july  and is headquartered in woburn ma director prior   radpharm inc radpharm is a leading imaging core lab managing the complete imaging segment of clinical trials for the global pharmaceutical biotechnology and medical device industries with greater than  years experience supporting over  clinical trials across  countries and  unique sites radpharms vast expertise spans early stage through phase iv studies and all major therapeutic areas in addition to having a specialty in oncology trials they also possess deep experience with cardiovascular musculoskeletal cns diagnostic contrast imaging agents and medical device studiesradpharm employs boardcertified subspecialty trained radiologists nuclear physicians and medical oncologists uniquely positioning us to focus on the medicine behind the imagetm its experienced medical staff interprets data from all major modalities including but not limited to computed tomography ct magnetic resonance imaging mri xray single photon emission computed tomography spect ultrasound positron emission tomography pet and petctthey provide centralized independent unbiased interpretation of medical images for clinical trials integrated with a proven planning tracking and implementation process specifically designed to exceed your expectations and timelines radpharm speeds delivery of your product to market by supporting your trial program with medical expertise regulatory knowhow and advanced validated technologiesradpharm inc provides oncology and medical imaging review services it also offers radiation therapy qa services oncology clinical reviews and complete medical photography services the company was founded in  by robert ford and is headquartered in princeton nj director    penwest pharmaceuticals co penwest pharmaceuticals co develops pharmaceutical products based on innovative proprietary oral drug delivery technologies penwest pharmaceuticals is a drug development company focuses on identifying and developing products that address unmet medical needs primarily for disorders of the nervous system the companys proprietary drug delivery technologies include timerx a controlledrelease technology geminex a technology enabling drug release at two different rates syncrodose a technology enabling controlled release at the appropriate site in the body and gastrodose system a technology enabling drug delivery to the upper gastrointestinal tract the company offers opana er an oral extended release opioid analgesic for patients with moderate to severe pain requiring continuous opioid treatment using its timerx drug delivery technology and nifedipine xl a generic version of procardia xl which is used for the treatment of hypertension and angina based on its timerx technology its products under development include nalbuphine er a phase ii clinical trail completed product for the treatment of pain and a a phase ii clinical trail product for the treatment of diseases related to the inherited mitochondrial respiratory chain diseases the company operates as a subsidiary of endo pharmaceuticals holdings inc penwest pharmaceuticals was founded in  and is headquartered in patterson ny director prior   intrabiotics pharmaceuticals inc intrabiotics a developer of antibiotics and antifungals is focused on one drug candidate iseganan hydrochloride oral solution which would be used for the prevention of ventilatorassociated pneumonia and to help cystic fibrosis patients fight respiratory infections director prior   aclara biosciences inc aclara biosciences inc discovers develops and markets innovative products to guide and improve treatment of serious viral immunologic and oncologic diseases independent director    ardea biosciences inc ardea biosciences inc is a biotechnology company which is focused on the development of smallmolecule therapeutics for the treatment of serious diseases it develops smallmolecule therapeutics for the treatment of human immunodeficiency virus and cancer and product candidates for the chronic management of hyperuricemia in gout patients the companys products are lesinurad rdea rdea and bay  rdea ardea biosciences was founded in january  and is headquartered in san diego ca director    trimeris inc trimeris inc develops therapeutics for viral diseases it is a biopharmaceutical company engaged in the discovery development and commercialization of novel therapeutic agents for the treatment of viral disease the core technology platform of fusion inhibition is based on blocking viral entry into host cells the company was founded in  and is headquartered in durham nc director   prior synageva biopharma corp synageva biopharma corp is a biopharmaceutical company which focuses on the discovery development and commercialization of therapeutic products for patients with lifethreatening rare diseases and high unmet medical need the company is currently evaluating sebelipase alfa in global clinical trials for lal deficiency a lysosomal storage disease associated with liver damage and accelerated atherosclerosis in children and adults and in infants premature death often before six months of age synageva biopharma was founded on november   and is headquartered in lexington ma political donations   william a halter team member at mckinsey  co inc public holdings restricted data only for relsci professional users start my free trial ➤ see more other affiliations kevin c tang is affiliated with tang capital management llc intrabiotics pharmaceuticals inc deutsche bank securities inc la jolla pharmaceutical co heron therapeutics inc prospect therapeutics inc radpharm inc penwest pharmaceuticals co intrabiotics pharmaceuticals inc aclara biosciences inc ardea biosciences inc trimeris inc synageva biopharma corp youve reached your  free profiles limit this month upgrade to relsci pro today to enjoy unlimited article views and much more start my free trial ➤ still not convinced check out our full listing of features here are you a relsci pro subscriber login to relsci pro  ➤ not a pro subscriber log in here to manage your alerts keep me signed in login  ➤ forgot your password i have read the lexisnexis terms  conditions sign me up  ➤ ardea biosciences  about us board of directors skip to content about us  management team board of directors collaborations contact us development pipeline  gout cancer scientific publications  presentations posters news  careers  job search view all jobs post resume member login working at ardea benefits hiring process diversity location contact us email alerts search ardea biosciences about us page sub navigation management team board of directors collaborations contact us page path breadcrumb home about us board of directors board of directors felix j baker phdmanaging partnerbaker bros advisors llc dr baker was appointed as one of our directors in february  dr baker currently serves as a managing partner of baker bros advisors llc the manager and advisor to the funds of baker brothers investments ardea’s largest shareholder baker brothers investments founded by felix and julian baker in  is a family of longterm investment funds for major endowments and foundations which are focused on publicly traded life sciences companies felix baker began his career as a fund manager by co founding a biotechnology investment partnership in  felix baker holds a bs and a phd in immunology from stanford university where he also completed two years of medical school top wendy l dixon phd dr dixon was appointed as one of our directors in april  from december  to may  dr dixon was chief marketing officer and president global marketing for bristolmyers squibb a biopharmaceutical company and served on the ceo’s executive committee from  to  she was senior vice president marketing at merck and prior to that she held executive management positions at west pharmaceuticals osteotech inc and centocor inc and various positions at smithkline  french pharmaceuticals now glaxosmithkline in marketing regulatory affairs project management and as a biochemist dr dixon serves on the boards of directors of furiex pharmaceuticals inc orexigen therapeutics inc incyte corporation and alkermes inc and was previously a director of dentsply international from  to  dr dixon received her msc and bsc in natural science and her phd in biochemistry from the university of cambridge dr dixon’s year career in the pharmaceutical and biotechnology business combining a technical background and experience in drug development and regulatory affairs with commercial responsibilities in building and leading organizations and launching and growing more than  pharmaceutical products including tagamet® fosamax® singulair® plavix® abilify® reyataz® and baraclude® brings to the board a wealth of broadranging and handson experience in drug developmenttop henry j fuchs mdsenior vice president and chief medical officerbiomarin pharmaceutical inc dr fuchs has served as one of our directors since november  dr fuchs currently serves as senior vice president and chief medical officer of biomarin pharmaceutical inc previously he served as executive vice president and chief medical officer of onyx pharmaceuticals he served as our chief executive officer from january  until june  dr fuchs joined us as vice president clinical affairs in october  and was appointed president and chief operating officer in november  from  to  dr fuchs held various positions at genentech where among other responsibilities he led the clinical program that resulted in the approval of genentech’s pulmozyme® dr fuchs was also responsible for the phase iii development program that led to the approval of herceptin® to treat metastatic breast cancer dr fuchs received an md degree from george washington university and a ba degree in biochemical sciences from harvard universitytop craig johnsonchief financial officerpure bioscience inc mr johnson has served as one of our directors since june  mr johnson currently serves as chief financial officer of pure bioscience inc prior to pure bioscience he served as senior vice president and chief financial officer of novedel pharma inc from  to  from  to  mr johnson served as vice president and chief financial officer of torreypines therapeutics inc from  to  he was employed by mitokor inc and last held the position of chief financial officer and senior vice president of operations prior to joining mitokor mr johnson served as a senior financial executive for several earlystage technology companies and he also practiced as a certified public accountant with price waterhouse mr johnson received his bba in accounting from the university of michigan and is a certified public accountanttop  john poyhonen mbapresident chief operating officersenomyx inc mr poyhonen was appointed as a director in june  mr poyhonen is currently the president and chief operating officer of senomyx inc he joined senomyx in october  as vice president and chief business officer and was promoted in april  to vice president and chief financial and business officer he was promoted to his current position in september  from  until october  mr poyhonen served in various sales and marketing positions for agouron pharmaceuticals a pfizer inc company most recently as vice president of national sales prior to holding this position mr poyhonen served as vice president of marketing and vice president of national accounts mr poyhonen received his ba in marketing from michigan state university and his mba from the university of kansastop barry d quart pharmdpresident chief executive officer and directorardea biosciences inc dr quart was elected as a director and appointed as our president and ceo in december  from  until december  dr quart was president of napo pharmaceuticals inc where he was instrumental in bringing the company public on the london stock exchange in july  prior to napo dr quart was senior vice president pfizer global research and development and the director of pfizers la jolla laboratories where he was responsible for approximately  employees and an annual budget of almost  million prior to pfizers acquisition of the warnerlambert company dr quart was president of research and development at agouron pharmaceuticals inc a division of the warnerlambert company since  dr quart had joined agouron in  and was instrumental in the development and registration of nelfinavir viracept® which went from the lab bench to nda approval in  months dr quart spent over ten years at bristolmyers squibb in both clinical research and regulatory affairs prior to agouron and was actively involved in the development and registration of important drugs for the treatment of hiv and cancer including paclitaxel taxol® didanosine videx® and stavudine zerit® he has a pharmd from university of california san francisco top kevin c tangmanaging directortang capital management llc mr tang has served as one of our directors since may  mr tang is the managing director of tang capital management llc a life sciencesfocused investment company he founded in august  from september  to july  mr tang held various positions at deutsche banc alex brown inc an investment banking firm most recently serving as managing director and head of the firms life sciences research group mr tang currently serves as a director of ap pharma inc mr tang received a bs degree from duke universitytop    terms of use privacy policy site map about us development pipeline scientific publications news careers  ardea inc